Molecular and pharmacological profiling of a prostate cancer PDX panel and in vitro cellular counterparts to identify resistance mechanisms and new therapeutic options

被引：0
|
作者：
Indersie, E. [1 ]
Sinayen, L. [1 ]
Bigot, L. [2 ]
Gorse, A. [1 ]
Tavernier, M. [1 ]
Le Ven, E. [1 ]
Friboulet, L. [2 ]
Farace, F. [2 ]
Morgado, E. [3 ]
Pouyet, L. [3 ]
Loriot, Y. [4 ]
Romagne, F. [3 ]
Deas, O. [1 ]
机构：
[1] XenTech, Res & Dev, Evry, France
[2] Gustave Roussy, Umr 981, Villejuif, France
[3] MImAbs, Immunopharmacol, Marseille, France
[4] Gustave Roussy, Dept Canc Med, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114785
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB258
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 14 条
  • [1] Molecular and pharmacological profiling of a novel prostate cancer-derived xenograft panel to identify resistance mechanisms and new therapeutic options
    Brulle-Soumare, Laura
    Bigot, Ludovic
    Mevel, Katell
    Le Ven, Enora
    Friboulet, Luc
    Besse, Benjamin
    Farace, Francoise
    Judde, Jean Gabriel
    Cairo, Stefano
    Loriot, Yohann
    Deas, Olivier
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Establishment, molecular and pharmacological profiling of novel prostate cancer-derived xenografts from patients with advanced, treatment-refractory, disease to identify resistance mechanisms and new therapeutic options
    Deas, Olivier
    Bigot, Ludovic
    Dasse, Emilie
    Andre, Fabrice
    Soria, Jean Charles
    Besse, Benjamin
    Cairo, Stefano
    Tavernier, Marie
    Mevel, Kate
    Le Ven, Enora
    Friboulet, Luc
    Judde, Jean Gabriel
    Loriot, Yohan
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Molecular profiling of bile duct and gallbladder cancer to identify different therapeutic options.
    Holcombe, Randall F.
    Xiu, Joanne
    Gatalica, Zoran
    Morse, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance
    Lima, Thiago S.
    Iglesias-Gato, Diego
    Souza, Luciano D. O.
    Stenvang, Jan
    Lima, Diego S.
    Roder, Martin A.
    Brasso, Klaus
    Moreira, Jose M. A.
    CANCERS, 2021, 13 (06) : 1 - 20
  • [5] New Panel of Molecular/Cellular Markers of Prostate Cancer for Risk Stratification
    Lin, Kirk
    Prasad, Anil
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 581 - 581
  • [6] New Panel of Molecular/Cellular Markers of Prostate Cancer for Risk Stratification
    Lin, Kirk
    Prasad, Anil
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 581 - 581
  • [7] MOLECULAR TUMOR PROFILING TO IDENTIFY MECHANISMS LINKING STATINS WITH LOWER RISK OF LETHAL PROSTATE CANCER
    Allott, Emma
    Noonan, Ericka
    Gonzalez-Feliciano, Amparo
    Markt, Sarah
    Wilson, Kathryn
    Ahearn, Thomas
    Gerke, Travis
    Downer, Mary
    Stopsack, Konrad
    Rider, Jennifer
    Freedland, Stephen
    Lotan, Tamara
    Kantoff, Philip
    Platz, Elizabeth
    Loda, Massimo
    Stampfer, Meir
    Giovannucci, Edward
    Sweeney, Christopher
    Finn, Stephen
    Mucci, Lorelei
    JOURNAL OF UROLOGY, 2018, 199 (04): : E261 - E262
  • [8] Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
    Feng, Ninghan
    Huang, Jiaoti
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (03) : 213 - 214
  • [9] Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
    Hashemi, Mehrdad
    Zandieh, Mohammad Arad
    Talebi, Yasmin
    Rahmanian, Parham
    Shafiee, Sareh Sadat
    Nejad, Melina Maghsodlou
    Babaei, Roghayeh
    Sadi, Farzaneh Hasani
    Rajabi, Romina
    Abkenar, Zahra Oryan
    Rezaei, Shamin
    Ren, Jun
    Nabavi, Noushin
    Khorrami, Ramin
    Rashidi, Mohsen
    Hushmandi, Kiavash
    Entezari, Maliheh
    Taheriazam, Afshin
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [10] Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naive, hormone-sensitive and castrate-resistant prostate cancer specimens
    Lassalle, Myriam
    Beraud, Claire
    Lang, Herve
    Lindner, Veronique
    Allory, Yves
    Potiron, Eric
    Massfelder, Thierry
    Lluel, Philippe
    Misseri, Yolande
    CANCER RESEARCH, 2020, 80 (16)
12